中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 9
Sep.  2019
Turn off MathJax
Article Contents

Establishment and evaluation of a predictive model for rebleeding after endoscopic treatment of esophageal and gastric varices

DOI: 10.3969/j.issn.1001-5256.2019.09.014
Research funding:

 

  • Received Date: 2019-05-15
  • Published Date: 2019-09-20
  • Objective To establish a predictive model for rebleeding after endoscopic injection of lauromacrogol combined with tissue adhesive in patients with esophageal and gastric varices, and to investigate its accuracy by cross validation. Methods A total of 180 patients with esophagogastric variceal bleeding who were admitted to Beijing Ditan Hospital from January 2014 to December 2016 were enrolled, and a retrospective analysis was performed for the clinical data of 126 patients, including age, sex, laboratory markers, Child-Pugh score, and degree of esophageal and gastric varices. A logistic regression analysis was used to screen out independent predictive factors for rebleeding and establish a predictive model, and the clinical data of the other 54 patients were used for cross validation of the accuracy of this model.The t-test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. The logistic regression method was used to perform multivariate analysis and establish the predictive model. The receiver operating characteristic ( ROC) curve was used for evaluation of this model and cross validation of its accuracy. Results The 1-year rebleeding rate was 46. 83% in 126 patients, and there were significant differences between the rebleeding group and the non-rebleeding group in platelet count ( t =-7. 488, P < 0. 001) , international normalized ratio ( t = 3. 145, P = 0. 002) , and degree of esophageal varices ( χ2= 8. 841, P = 0. 031) . The multivariate logistic regression analysis showed that sex ( odds ratio [OR]= 3. 366, 95% confidence interval [CI]: 1. 015-11. 166, P = 0. 047) , platelet count ( OR = 0. 922, 95% CI: 0. 893-0. 951, P < 0. 001) , and degree of esophageal varices ( OR = 2. 422, 95% CI: 1. 179-4. 977, P = 0. 016) were independent predictive factors for rebleeding. The predictive model based on the combination of these three factors had an area under the ROC curve of 0. 876, a sensitivity of 86. 0%, and a specificity of 83. 1%.Cross validation based on the clinical data of the other 54 patients showed that this predictive model had an accuracy of 92. 6%. Conclusion Male sex and severe varices are high-risk factors for rebleeding, and platelet count is a protective factor. The predictive model based on thecombination of these three factors has a certain value in predicting rebleeding, with an accuracy of 92.6%.

     

  • loading
  • [1] LO GH. Endoscopic treatments for portal hypertension[J].Hepatol Int, 2018, 12 (suppl 1) :91-101.
    [2] HERNANDEZ-GEA V, BERBEL C, BAIGES A, et al. Acute variceal bleeding:Risk stratification and management (including TIPS) [J]. Hepatol Int, 2018, 12 (Suppl 1) :81-90.
    [3] SHI KQ, LIU WY, PAN ZZ, et al. Secondary prophylaxis of variceal bleeding for cirrhotic patients:A multiple-treatments meta-analysis[J]. Eur J Clin Invest, 2013, 43 (8) :844-854.
    [4] ALBILLOS A, TEJEDOR M. Secondary prophylaxis for esopgageal variceal bleeding[J]. Clin Liver Dis, 2014, 18 (2) :359-370.
    [5] GARBUZENKOD V. Contemporary concepts of the medical therapy of portal hypertension under liver cirrohsis[J]. World J Gastroenterol, 2015, 21 (20) :6117-6126.
    [6] TSOCHATZIS EA, BOSCH J, BURROUGHS AK. Liver cirrhosis[J]. Lancet, 2014, 383 (9930) :1749-1761.
    [7] Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Endoscopy, Chinese Medical Association. Guidelines for the diagnosis and treatment of esophageal and gastric vaiceal bleeding in cirrohotic portal hypertension[J]. J Clin Hepatol, 2016, 32 (2) :203-219. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].临床肝胆病杂志, 2016, 32 (2) :203-219.
    [8] MENG Z, HU YF, LIANG DS, et al. Clinical analysis of early rebleeding after endoscopic esophageal variceal ligation in the treatment of liver cirrhosis with esophageal varices[J]. China Foreign Med Treatment, 2016, 16 (61) :61-63. (in Chinese) 蒙钊, 胡艳芳, 梁冬生, 等.肝硬化食管静脉曲张内镜下套扎治疗术后早期再出血的临床分析[J].中外医疗, 2016, 16 (61) :61-63.
    [9] WANG WP, FENG J, XU L, et al. Predictive indicators of esophageal varices bleeding in hepatitis patients with liver cirrhosis[J]. Chin Gen Pract, 2015, 18 (22) :2676-2678. (in Chinese) 王万鹏, 冯静, 许蕾, 等.肝炎肝硬化患者并发食管胃底静脉曲张破裂出血的预测指标研究[J].中国全科医学, 2015, 18 (22) :2676-2678.
    [10] HE Y, SU YR, HAN ZY. Current status of research on primary and secondary risk factors for esophagogastric variceal rebleeding in patients with liver cirrhosis[J]. J Clin Hepatol, 2018, 34 (7) :1555-1559. (in Chinese) 何阳, 苏亚荣, 韩子岩.肝硬化食管胃静脉曲张破裂再出血的主次危险因素研究现状[J].临床肝胆病杂志, 2018, 34 (7) :1555-1559.
    [11] TERRAULT NA, LOK ASF, MCMAHON BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018, 67 (4) :1560-1599.
    [12] ROGALSKI P, ROGALSKA M, WROBLEWSKI E, et al. Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history[J].Scand J Gastroenterol, 2019, 23 (3) :1-8.
    [13] GAO LL, ZHANG YJ, GAO XS, et al. Prediction of esophageal varices in patients with hepatitis C-associated liver cirrhosis by non-invasive markers[J/CD]. Chin J Liver Dis:Electr Version, 2018, 10 (3) :73-76. (in Chinese) 高丽丽, 张亦瑾, 高学松.无创性指标预测丙型肝炎肝硬化患者食管静脉曲张[J/CD].中国肝脏病杂志:电子版, 2018, 10 (3) :73-76.
    [14] WANG J, ZHENG GZ. Factors related to esophageal variceal bleeding in patients with liver cirrhosis[J/CD]. Chin J Liver Dis:Electr Version, 2019, 11 (1) :42-46. (in Chinese) 王娟, 郑鸽之.肝硬化食管静脉曲张破裂出血相关因素分析[J/CD].中国肝脏病杂志:电子版, 2019, 11 (1) :42-46.
    [15] DING HG, ZHANG SB, LI L, et al. Endoscopic diagnosis and treatment of esophageal and gastric varices in patients with liver cirrhosis:From guidelines to clinical practice[J]. J Clin Hepatol, 2017, 33 (3) :454-457. (in Chinese) 丁惠国, 张世斌, 李磊, 等.肝硬化食管胃底静脉曲张的内镜诊断治疗-从指南到临床实践[J].临床肝胆病杂志, 2017, 33 (3) :454-457.
    [16] ZHOU HH, LI CT, SHI SL. Related factors for rebleeding within 1 year after endoscopic therapy for esophageal variceal bleeding[J]. J Clin Med, 2016, 3 (16) :3187-3188. (in Chinese) 周海华, 李池添, 石胜利.食管静脉曲张破裂出血内镜治疗后1年内再出血的相关因素分析[J].临床医药文献杂志, 2016, 3 (16) :3187-3188.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1337) PDF downloads(235) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return